MATEON THERAPEUTICS INC Compensation Agreements
7 Contracts & Agreements
- MATEON THERAPEUTICS, INC. AMENDED AND RESTATED DIRECTOR COMPENSATION POLICY AS IN EFFECT OCTOBER 25, 2016 (Filed With SEC on October 28, 2016)
- OXiGENE, INC. AMENDEDAND RESTATED DIRECTOR COMPENSATION POLICY (Filed With SEC on August 8, 2014)
- EX-10.2 OXiGENE, Inc. Amended and Restated Director Compensation Policy (Filed With SEC on October 24, 2008)
- EX-10.3 Description of Named Executive Officer Compensation Arrangements (Filed With SEC on July 29, 2005)
- EX-10.2 Description of Director Compensation Arrangements (Filed With SEC on July 29, 2005)
- EX-10.42 NAMED EXECUTIVE OFFICERS COMPENSATION ARRANGEMENTS (Filed With SEC on March 15, 2005)
- EX-10.41 DESCRIPTION OF DIRECTOR COMPENSATION (Filed With SEC on March 15, 2005)